BriaCell Therapeutics Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCT.TO | HURA | MDNA.TO | APLM | CHRS | PDSB | |
|---|---|---|---|---|---|---|
| Market cap | 42.45M | 112.16M | 41.54M | 61.51M | 152.96M | 81.90M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -9.0 | -2.9 | -2.0 | -32.5 | -1.6 | -3.3 |
| Price/book | 1.0 | 6.2 | 25.0 | -14.2 | 2.5 | -17.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −71.43% | −28.16% | −51.11% | −42.70% | −44.69% | +15.42% |
| Today | −8.96% | −3.83% | +2.27% | −0.00% | −7.48% | −13.08% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCT.TO news ›BriaCell Therapeutics (CVE:BCT) Stock Price Down 3.8% – Here’s What Happened
BriaCell Therapeutics Corp. (CVE:BCT – Get Free Report)’s stock price fell 3.8% during mid-day trading on Tuesday. The stock traded as low as C$10.60 and last traded at C$10.60. Approximately 3,402 shares were traded during mid-day…
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Presentation details are listed below. Title: Development of BP-80, a soluble CD80 dimer (CD80-Fc) for cancer treatment Date: Friday, Nov. 6, 2026 Title: Molecular design of CD80 variants with increased affinity for PD-L1 and wild-type or…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net1
-
themarketsdaily.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.